This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Mar;100(3):599-603.
doi: 10.4269/ajtmh.18-0652.

Case Report: Two Cases of Cholangiocarcinoma in Patients with Opisthorchis felineus Infection in Western Siberia, Russian Federation

Affiliations
Case Reports

Case Report: Two Cases of Cholangiocarcinoma in Patients with Opisthorchis felineus Infection in Western Siberia, Russian Federation

Yulia V Kovshirina et al. Am J Trop Med Hyg. 2019 Mar.

Abstract

Cholangiocarcinoma (CCA) is a cancer with high mortality owing to its aggressiveness and resistance to therapy. The liver flukes of the Opisthorchiidae family have been recognized as risk factors of CCA. Opisthorchis felineus infection occurs in Western Siberia, the biggest endemic area in the Russian Federation, and is associated with chronic inflammation of the bile ducts, which may be linked to severe hepatobiliary morbidity. We report two cases of confirmed CCA who had a chronic O. felineus infection. Both cases presented unspecific symptoms at the onset of the disease, a stage when severe pathological changes already had occurred. Both patients were living in endemic areas but did not receive any antihelminthic treatment. This report underlines the need for assessment of O. felineus infection as a causative factor of CCA. The results will provide further arguments for control of O. felineus in the Russian Federation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Case 1. Magnetic resonance imaging: signs of cholangiocarcinoma (axial view). (A) Enlarged intrahepatic bile ducts; (B) the common bile duct is not distinctly differentiated within 1.0 cm; its diameter is enlarged up to 1.0 cm in the proximal and middle part.
Figure 2.
Figure 2.
Case 1. Histology of liver parenchyma: a moderately differentiated tubular adenocarcinoma with desmoplastic reaction is found. A small ductular carcinoma grows in desmoplastic stroma. Hematoxylin and eosin stain (original magnification, ×ばつ40). This figure appears in color at www.ajtmh.org.
Figure 3.
Figure 3.
Case 2. Magnetic resonance imaging: signs of cholangiocarcinoma (sagittal view). Tumor in the right lobe of liver with bile hypertension, involving biliary cyst and defeat of regional lymphatic nodes. (A) Mass-like enlargement with unclear contours; (B) enlarged intrahepatic bile ducts.
Figure 4.
Figure 4.
Case 2. Histology of liver parenchyma: bile ductular type of intrahepatic cholangiocarcinoma. Epithelial cells are cuboidal with eosinophilic cytoplasm and round central nuclei; tumor cells are heterogeneous and resemble bile duct cells. Poorly differentiated carcinoma grows in fibrous stroma and has cord-like growth. Hematoxylin and eosin stain (original magnification, ×ばつ20). This figure appears in color at www.ajtmh.org.
Figure 5.
Figure 5.
Case 2. Histology of liver parenchyma: Opisthorchis felineus adult worms in intrahepatic bile duct. Hematoxylin and eosin stain (original magnification, Plan ×ばつ5). This figure appears in color at www.ajtmh.org.

References

    1. Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM, Gores GJ, 2014. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 60: 1268–1289. - PubMed
    1. Bragazzi MC, Cardinale V, Carpino G, Venere R, Semeraro R, Gentile R, Gaudio E, Alvaro D, 2012. Cholangiocarcinoma: epidemiology and risk factors. Transl Gastrointest Cancer 1: 21–32.
    1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, 2002. Cancer incidence in five continents. Volume VIII. IARC Sci Publ 3: 1–781. - PubMed
    1. Banales JM, et al. 2016. Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev Gastroenterol Hepatol 13: 261–280. - PubMed
    1. Palmer WC, Patel T, 2012. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 57: 69–76. - PMC - PubMed

Publication types

Full text links
Sheridan PubFactory full text link Sheridan PubFactory Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /